1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Drug Delivery Insight 29 SEPTEMBER 2014

Drug Delivery Insight 29 SEPTEMBER 2014

  • October 2014
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Respiratory Market Stratification Inevitable, Augmented By ERS Revelations
Industry Brief - Genisphere Completes Fundraising For Drug-Delivery Technology
Industry Brief - Ligand Licenses Captisol-enabled Lamotrigine To CURx
Industry Brief - MedGenesis/Pfizer Enter Agreement For Potential PD Treatments
Industry Brief - 3SBio Gains Exclusive Chinese Licence For JenKem's PEG-Irinotecan
Industry Brief - Merck Serono/Sutro Collaborate To Develop ADCs
Industry Brief - Nanobiotix Opens Office In Boston
Industry Brief - Generex/UHN Enter Buccal Insulin Collaboration
Industry Brief - NovaDel Sells ZolpiMist NDA/Licence/Intellectual Property To Amherst
Industry Brief - Acorda To Acquire Civitas Therapeutics
Industry Brief - Galen Agrees To Sell Penthrox In UK/Ireland
Industry Brief - MannKind/Sanofi Close Global Licensing Deal For Afrezza
Industry Trend Analysis - Lilly's Trulicity Approval To Pave Way For Medium-Term GLP-1 Market Domination
Industry Brief - Dr Reddy's Launches Levalbuterol Inhalation Solution In US
Industry Brief - Chiesi Launches Fostair NEXThaler For Adult Asthma
Industry Brief - FDA Approves New Dose Of Minivelle For Postmenopausal Osteoporosis
Industry Brief - FDA Approves Spiriva Respimat Inhalation Spray For COPD
Industry Brief - Ozurdex FDA-Approved For Treating Macular Oedema
Industry Brief - Iluvien Granted FDA Approval For DMO
Industry Brief - FDA Grants Orphan Drug Status To Lynovex For CF
Industry Brief - Vaxxas To Evaluate Nanopatch Platform For Polio Vaccine Delivery
Industry Brief - AMI-Licensed Brachytherapy Seed Product Granted US Patent
Industry Brief - Agile Initiates Phase III Study For Twirla Contraceptive Patch
Industry Brief - Soligenix Receives FDA Clearance Of SGX301 Phase III Protocol In CTCL
Industry Brief - FDA Grants Expanded Access Use Of Tekmira's TKM-Ebola
Industry Brief - Novavax Initiates Phase II Trial Of RSV F Vaccine
Industry Brief - Positive Interim Data From ITCA 650 Phase III Trial Highlighted
Industry Brief - CHMP Issues Positive Opinion On Aclidinium/Formoterol
Industry Brief - Drug Delivery Conferences - October 2014

Table Of Contents

Drug Delivery Insight 29 SEPTEMBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in the UK

  • January 2017
    19 pages
  • Therapy  

  • United Kingdom  

View report >

Global Therapy Market

  • January 2017
    32 pages
  • Therapy  

    Targeted Therap...  

    Monoclonal Anti...  

  • World  

View report >

Infectious Disease Statistics and Anti-Infective Market in India - Forecast

  • January 2017
    7 pages
  • Infectious Dise...  

    Anti-Infective  

  • India  

View report >

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.